Highlights and Quick Summary
- EBT margin for the quarter ending June 30, 2023 was -74.05% (a -24.11% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin increased by 178.07%
- Annual EBT margin for 2022 was -19.78% (a -212.77% decrease from previous year)
- Annual EBT margin for 2021 was 17.54% (a -33.0% decrease from previous year)
- Annual EBT margin for 2020 was 26.18% (a 274.0% increase from previous year)
- Twelve month EBT margin ending June 30, 2023 was -50.89% (a 31.4% increase compared to previous quarter)
- Twelve month trailing EBT margin decreased by -758.34% year-over-year
Trailing EBT margin for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -50.89% | -38.73% | -19.78% | 7.73% |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of Emergent Biosolutions Inc.
Most recent EBT marginof EBS including historical data for past 10 years.Interactive Chart of EBT margin of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. EBT margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -74.05% | -97.58% | – | – | – |
| 2022 | -21.53% | -26.63% | -34.12% | -1.24% | -19.78% |
| 2021 | 36.99% | -13.83% | 1.81% | 24.84% | 17.54% |
| 2020 | 43.36% | 14.28% | 30.58% | -11.06% | 26.18% |
| 2019 | 19.81% | 18.89% | -6.21% | -19.83% | 7.0% |
| 2018 | 1.33% | 12.38% | 29.88% | -7.98% | 10.42% |
| 2017 | 26.79% | 30.99% | 6.67% | 11.68% | 21.14% |
| 2016 | 32.37% | 23.48% | -3.63% | 19.28% | 20.29% |
| 2015 | 59.32% | 39.24% | 15.54% | -46.81% | 27.74% |
| 2014 | 73.74% | 21.53% | 6.79% | -52.78% | 20.82% |
| 2013 | 24.11% | 20.53% | 17.88% | -30.91% | 13.87% |
| 2012 | 25.67% | 14.8% | – | – | 11.38% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic